Cold Chain

Merck joins Volansi in collaborative effort to use the emerging technology in the healthcare supply chain

The temperature-controlled containers will be introduced across all flights for large pharma shipments

The deal with unnamed large pharmaceutical company reportedly won’t include vaccine transport

Survey results indicate that only 28 percent of the air cargo industry feels well prepared at this point

Agreement delivers quartz vials in secondary packaging to streamline fill-finish operations for early phase drug development

But volume and price dynamics remain volatile and uncertainty remains

Ultralow temperatures require a revision of vaccine distribution technology

Plant targets Covid-19 vaccine supply for Israel, Europe and elsewhere

Technology offers direct replacement for diesel systems and can be retrofitted into existing trailers

New capabilities help pharmaceutical and other companies make faster and more effective shipping decisions

Pre-qualified 2-8°C shippers are designed for vaccines and biologics

Company scaling up manufacturing capacity and anticipates compatibility with its standard distribution channels

Move aims to bolster safety and security from origination to delivery

The purchases boost its position in temperature-controlled life sciences

Air carrier has a 54-station network centered in Abu Dhabi

Agile approaches to averting vaccine wastage will be critical to global delivery ramp-up

The role of these tools amid evolving regulatory, geography, and accessibility considerations

Both COVID-19 vaccine delivery and the growth of cellular/genetic therapies call for lower storage and shipping temperatures

Aphena Pharma and Life Science Logistics announce new facilities as preparations for Covid-19 treatment evolve

Atelerix wins another round of funding from a UK innovation sponsor

The SenseAware ID technology is expected to be used in Covid-19 shipments

Both during and after vaccine distribution, the pharma cold chain will be vastly expanded

Data is beginning to trickle out on storage and shipping conditions for the new vaccines

Deal is boosted by a $275-million investment from Blackstone Group

$58-million acquisition nearly doubles Cryoport’s size